Cargando…

Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study

BACKGROUND: We aimed to explore the benefit of splenectomy combined with curative treatments (liver resection or local ablation) for patients with hepatocellular carcinoma and portal hypertension. METHODS: The records of 239 patients with hepatocellular carcinoma and portal hypertension undergoing e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Youliang, Chai, Songshan, Zhang, Yuxin, Zhang, Zhanguo, Chen, Xiaoping, Zhang, Wanguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831533/ https://www.ncbi.nlm.nih.gov/pubmed/30511133 http://dx.doi.org/10.1007/s11605-018-3981-9

Ejemplares similares

Improved survival following splenectomy combined with curative treatments for hepatocellular carcinoma in Child B patients: A propensity score matching study
por: Pei, Youliang, et al.
Publicado: (2019)

The Benefits of Radical Treatments with Synchronous Splenectomy for Patients with Hepatocellular Carcinoma and Portal Hypertension
por: Zhang, Qikun, et al.
Publicado: (2022)

Reliable reconstruction of the complex high-location bile duct injury: a novel hepaticojejunostomy
por: Zhang, Yuxin, et al.
Publicado: (2019)

Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes
por: Liu, Furong, et al.
Publicado: (2020)

Splenectomy before hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A retrospective study
por: Zhou, Chenyang, et al.
Publicado: (2021)

Construction and Validation of a Nomogram for Predicting the Risk of Deep Vein Thrombosis in Hepatocellular Carcinoma Patients After Laparoscopic Hepatectomy: A Retrospective Study
por: Chen, Yao, et al.
Publicado: (2021)

Preoperative risk grade predicts the long-term prognosis of intrahepatic cholangiocarcinoma: a retrospective cohort analysis
por: Zhao, Jianping, et al.
Publicado: (2021)

Incomplete radiofrequency ablation provokes colorectal cancer liver metastases through heat shock response by PKCα/Fra-1 pathway
por: Zhang, Zhanguo, et al.
Publicado: (2019)

Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy
por: Chai, Zong-Tao, et al.
Publicado: (2021)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

Laparoscopic splenectomy and esophagogastric devascularization combined with fast-track principles offers greater benefit for patients with portal hypertension
por: Wang, Dong, et al.
Publicado: (2022)

Hepatic Resection for Hepatocellular Carcinoma in Patients With Portal Hypertension: A Long-Term Benefit Compared With Transarterial Chemoembolization and Thermal Ablation
por: Xiao, Hua, et al.
Publicado: (2015)

Intentional Modulation of Portal Venous Pressure by Splenectomy Saves the Patient with Liver Failure and Portal Hypertension After Major Hepatectomy: Is Delayed Splenectomy an Acceptable Therapeutic Option for Secondary Portal Hypertension?
por: Takamatsu, Yuichi, et al.
Publicado: (2018)

Long-term efficacy of subtotal splenectomy due to portal hypertension in cirrhotic patients
por: Chu, Haibo, et al.
Publicado: (2015)

Comparison of simplified and traditional pericardial devascularisation combined with splenectomy for the treatment of portal hypertension
por: Zhang, Ya-Fei, et al.
Publicado: (2018)

Elective Splenectomy Combined with Modified Hassab's or Sugiura Procedure for Portal Hypertension in Decompensated Cirrhosis
por: Zhang, Ya-wu, et al.
Publicado: (2019)

Laparoscopic selective esophagogastric devascularization and splenectomy for patients with cirrhotic portal hypertension
por: Lin, Jie, et al.
Publicado: (2018)

Laparoscopic splenectomy and porto-azygos disconnection: clinical research in the treatment of portal hypertension
por: Fengyong, Wang, et al.
Publicado: (2015)

Prior Esophagogastric Devascularization Followed by Splenectomy for Liver Cirrhosis with Portal Hypertension: A Modified Laparoscopic Technique
por: Zhang, Lei, et al.
Publicado: (2019)

Laparoscopic RFA with splenectomy for hepatocellular carcinoma
por: Hu, Kunpeng, et al.
Publicado: (2016)

Benefits of Local Treatment Including External Radiotherapy for Hepatocellular Carcinoma with Portal Invasion
por: Lee, Han Ah, et al.
Publicado: (2021)

Machine learning predicts portal vein thrombosis after splenectomy in patients with portal hypertension: Comparative analysis of three practical models
por: Li, Jian, et al.
Publicado: (2022)

P-Selectin Level at First and Third Day After Portal Hypertensive Splenectomy for Early Prediction of Portal Vein Thrombosis in Patients With Cirrhosis
por: Wei, Yunhai, et al.
Publicado: (2018)

Portal Hypertension: Effect of Early Splenic Artery Ligation on Platelets Count During Splenectomy
por: Bhavsar, Mahendra S., et al.
Publicado: (2012)

Spleen bed laparoscopic splenectomy plus pericardial devascularization for elderly patients with portal hypertension
por: Yan, Cao, et al.
Publicado: (2022)

Splenectomy with endotherapy in non-cirrhotic portal fibrosis related portal hypertension: Can it be an alternative to proximal spleno-renal shunt?
por: Saluja, Sundeep Singh, et al.
Publicado: (2020)

Preventive use of low molecular weight heparin in portal vein system thrombosis after splenectomy without portal hypertension
por: Wei, Qiang, et al.
Publicado: (2022)

Clinical efficacy of total laparoscopic splenectomy for portal hypertension and its influence on hepatic hemodynamics and liver function
por: Qi, Rui-Zhao, et al.
Publicado: (2023)

Risk Factors for a High Comprehensive Complication Index after Splenectomy Plus Pericardial Devascularization for Portal Hypertension
por: Zhang, Yafei, et al.
Publicado: (2023)

Prediction of the Factors Influencing the Shengjing Classification of Portal Vein Thrombosis after Splenectomy for Portal Hypertension in Cirrhosis: A Single-Center Retrospective Case-Control Study
por: Song, Zimin, et al.
Publicado: (2020)

ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
por: Liu, Furong, et al.
Publicado: (2020)

Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism
por: Zhang, Er-Lei, et al.
Publicado: (2023)

Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma
por: Beppu, Toru, et al.
Publicado: (2020)

Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters
por: Sidali, Sabrina, et al.
Publicado: (2022)

Successful treatment of portal hypertension from splenic arteriovenous fistula by coil embolization followed by splenectomy
por: Lomeli, Luis D., et al.
Publicado: (2013)

Left-sided portal hypertension: Successful management by laparoscopic splenectomy following splenic artery embolization
por: Patrono, Damiano, et al.
Publicado: (2014)

Efficacy and safety of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension: A single-center experience
por: Zheng, Shunzhen, et al.
Publicado: (2018)

Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension
por: Lv, Yunfu, et al.
Publicado: (2021)

Preoperative splenic artery embolism followed by splenectomy is safe and effective in patients with sinistral portal hypertension
por: Wang, Zihe, et al.
Publicado: (2021)

Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension
por: Zhong, Jian-Hong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bfma3bbss96tadfjddq1utpc19